• Home >
• About Freeslate >
• Company >
• Freeslate Difference

The Freeslate Difference

At the most fundamental level, Freeslate provides integrated, automated systems for high throughput research. But what differentiates us is the scientific expertise in high throughput research—applied expertise in engineering and workflows, materials science, software, and systems integration—that we can apply to your unique R&D challenges.

Your mission is clear: Make discoveries that lead to new products, new processes, and new opportunities. And you've got the scientific expertise and the R&D resources to get there. But we’re sure you’re also challenged to improve the productivity and effectiveness of your R&D efforts—and our combination of products, experience, and insight for high throughput research can help.

Our goal is to deliver "step-change gains": dramatic improvements in the return on investment (ROI) of your R&D, which is exactly what we've done in the past, and are doing today. Freeslate pioneered the application of high throughput technologies in consumer products. Freeslate was the first to introduce high throughput technologies to the research challenges of polyolefins and polymers. Today, Freeslate is leading the way in high throughput technologies for drug development.

In short, we know how to work with you to understand your R&D challenges and to develop a solution that leads to breakthroughs—as we've done for many customers in many markets. And we can back up that claim. Our customers:

• Created new products

  AGFA developed its DirectriX detector technology for DX-S Computed Radiography with Freeslate technology.

• Reduced R&D costs

  Pharmaceutical giant Merck used Freeslate microscale technologies to save more than $70 million over five years (and won the Astra Zeneca IChemE Award for Excellence in Green Chemistry).

• Entered new markets

  Government research organization Pacific Northwest National Laboratory employed Freeslate solutions to discover a new catalyst to convert glucose into HMF, offering entry into the biorenewables market.

• Improved product yield

  Using Freeslate technology, ExxonMobil developed several catalysts for its refining processes including a selective HDS catalyst that results in higher octane gasoline.

• Improve R&D efficiency

  Eli Lilly used Freeslate solutions to achieve a 90% reduction in testing time required for scientists to submit an NDA which resulted in a 3x-6x increase in productivity in the laboratory.

And we've provided this kind of value to clients on numerous other projects.

Click here to learn more about how Freeslate can help you deliver dramatic gains in your R&D.